Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexicon Pharmaceuticals

0.7667
+0.04976.93%
Pre-market: 0.78000.0133+1.73%08:51 EDT
Volume:6.26M
Turnover:4.78M
Market Cap:278.45M
PE:-1.51
High:0.7943
Open:0.7200
Low:0.7200
Close:0.7170
Loading ...

Lexicon Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for Rachel Yap Martens, VP of Partnerships & Corp Strat

Reuters
·
07 Jun

Lexicon Pharmaceuticals Inc. Concluded Annual Stockholders Meeting

Reuters
·
04 Jun

Lexicon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Lexicon Pharmaceuticals Q1 Operating Income USD -25.679 Million

Reuters
·
14 May

Lexicon Pharmaceuticals Q1 EPS $(0.07) Beats $(0.10) Estimate, Sales $1.26M Miss $1.41M Estimate

Benzinga
·
14 May

Lexicon Pharmaceuticals Reports Q1 2025 Net Loss of $25.3M, EPS Improves to $0.07 from $0.20 in 2024

Reuters
·
14 May

Lexicon Pharmaceuticals Inc: on Track for Next Steps in Pilavapadin's Development, Including Our End of Phase 2 Meeting With FDA

THOMSON REUTERS
·
14 May

Lexicon Pharmaceuticals Q1 Operating Expenses USD 26.941 Million

THOMSON REUTERS
·
14 May

Lexicon Pharmaceuticals options imply 25.9% move in share price post-earnings

TIPRANKS
·
14 May

Lexicon Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
10 May

Lexicon Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
29 Apr

LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?

Zacks
·
02 Apr

Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
02 Apr

Social Buzz: Wallstreetbets Stocks Mixed Premarket Tuesday; Tesla to Advance, Lexicon Pharmaceuticals to Decline

MT Newswires Live
·
01 Apr

US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst

Benzinga
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

Lexicon Pharmaceuticals Shares up 65% on Licensing Deal With Novo Nordisk for Obesity Drug Candidate

THOMSON REUTERS
·
28 Mar

Lexicon Pharmaceuticals Shares Soar on Novo Nordisk Licensing Deal

Dow Jones
·
28 Mar

BUZZ-Lexicon surges on licensing deal with Novo Nordisk for obesity drug

Reuters
·
28 Mar

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal

Reuters
·
28 Mar